News Releases

September 22, 2021 at 4:25 PM EDT

Summary Toggle Anthony Semedo Joins CryoLife Board of Directors

ATLANTA , Sept. 22, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today the appointment of Anthony "Tony" Semedo to its Board of Directors effective October 1, 2021 .
August 31, 2021 at 4:25 PM EDT

Summary Toggle CryoLife to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

ATLANTA , Aug. 31, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Morgan Stanley 19 th Annual Global Healthcare Conference on Tuesday, September 14, 2021 .
August 2, 2021 at 4:30 PM EDT

Summary Toggle CryoLife to Participate in Upcoming Virtual Investor Conferences

ATLANTA , Aug. 2, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming virtual investor conferences. CryoLife's management team will present at the upcoming Canaccord
July 29, 2021 at 4:05 PM EDT

Summary Toggle CryoLife Reports Second Quarter 2021 Financial Results

ATLANTA , July 29, 2021 /PRNewswire/ -- Second Quarter and Recent Business Highlights: Achieved total revenues of $76.1 million in the second quarter 2021 versus $53.8 million in the second quarter of 2020, an increase of 42% on a GAAP basis and 35% on a non-GAAP proforma constant currency
July 29, 2021 at 8:00 AM EDT

Summary Toggle CryoLife Announces Sale of PerClot to Baxter

ATLANTA , July 29, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has completed the sale of its PerClot product line to a subsidiary of Baxter International, Inc.
July 15, 2021 at 4:25 PM EDT

Summary Toggle CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results

ATLANTA , July 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2021 financial results will be released on Thursday, July 29, 2021 after the market closes. On that day, the Company
May 18, 2021 at 8:35 AM EDT

Summary Toggle CryoLife to Participate in the UBS Global Healthcare Virtual Conference

ATLANTA , May 18, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021 .
April 29, 2021 at 4:05 PM EDT

Summary Toggle CryoLife Reports First Quarter 2021 Financial Results

ATLANTA , April 29, 2021 /PRNewswire/ -- First Quarter and Recent Business Highlights: Achieved total revenues of $71.1 million in the first quarter 2021 versus $66.4 million in the first quarter of 2020, an increase of 7% on a GAAP basis and 3% on a non-GAAP proforma constant currency basis
April 15, 2021 at 8:35 AM EDT

Summary Toggle CryoLife Announces Release Date and Teleconference Call Details for First Quarter 2021 Financial Results

ATLANTA , April 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2021 financial results will be released on Thursday, April 29, 2021 after the market closes. On that day, the Company
April 7, 2021 at 8:35 AM EDT

Summary Toggle CryoLife to Participate in 20th Annual Needham Virtual Healthcare Conference

ATLANTA , April 7, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 20 th Annual Needham Virtual Healthcare Conference on Wednesday, April 14, 2021 . The Company's